| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |